Group One Trading
CRBU icon

Group One Trading’s Caribou Biosciences CRBU Stock Holding History

Group One Trading’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.7K Sell
48,800
-16,300
-25% -$28K ﹤0.01% 4804
2025
Q4 		$104K Buy
65,100
+32,800
+102% +$68.8K ﹤0.01% 4980
2025
Q3 		$75.3K Buy
32,300
+15,900
+97% +$30K ﹤0.01% 5593
2025
Q2 		$20.7K Sell
16,400
-1,300
-7% -$1.28K ﹤0.01% 6246
2025
Q1 		$16.2K Buy
17,700
+5,400
+44% +$7.02K ﹤0.01% 5957
2024
Q4 		$19.6K Sell
12,300
-5,800
-32% -$11.7K ﹤0.01% 5700
2024
Q3 		$35.5K Buy
18,100
+17,500
+2,917% +$35.8K ﹤0.01% 4880
2024
Q2 		$984 Sell
600
-10,500
-95% -$33.6K ﹤0.01% 6362
2024
Q1 		$57.1K Buy
11,100
+10,800
+3,600% +$66.6K ﹤0.01% 4607
2023
Q4 		$1.72K Sell
300
-19,700
-99% -$97.4K ﹤0.01% 6869
2023
Q3 		$95.6K Buy
20,000
+19,600
+4,900% +$122K ﹤0.01% 4501
2023
Q2 		$1.7K Buy
400
+200
+100% +$899 ﹤0.01% 7131
2023
Q1 		$1.06K Sell
200
-1,100
-85% -$6.85K ﹤0.01% 6778
2022
Q4 		$8.16K Buy
+1,300
New +$11.6K ﹤0.01% 6111

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's CRBU Position: Q4 2025 in Review

Group One Trading sold out of Caribou Biosciences (CRBU) in Q4 2025, closing a stake of 6,084 shares — an estimated $12.8K sold.

Group One Trading first reported a position in CRBU in Q2 2022 and held it in 11 quarters. The position peaked at $32.7K in Q2 2025. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Group One Trading reported no remaining Caribou Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 6,084 Caribou Biosciences shares in Q4 2025, an estimated $12.8K.
  • Group One Trading first reported a position in Caribou Biosciences in Q2 2022 and held it in 11 quarters.
  • Group One Trading's Caribou Biosciences position peaked at $32.7K in Q2 2025.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.